Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

NCT03890614 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy

Interventions

OTHER: Ancillary-Correlative - Creation of three-dimensional myeloma organoids using marrow aspirates

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]